微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.56% | 124% | 108.68% | 95/158 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -6.45% | -2704.35% | -258.33% | 118/158 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | -1.8% | -139.56% | -22.45% | 123/158 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -1.47% | -142.61% | -688% | 124/158 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.25% | -80.92% | 208.7% | 111/158 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -0.23% | -117.29% | -105.05% | 103/158 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 4.55% | 38.3% | 31.88% | 76/158 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 3.45% | 151.82% | 163.36% | 62/158 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.31% | -35.15% | -1.5% | 77/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 1.33% | -43.16% | -59.57% | 99/158 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 3.29% | 23.68% | 140.15% | 81/158 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 1.37% | -28.65% | -32.18% | 97/158 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 2.02% | 152.5% | -13.68% | 59/158 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 2.34% | 115.4% | -12.03% | 97/158 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 2.66% | 240% | 38.54% | 97/158 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 1.92% | 158.01% | 140% | 99/158 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 0.8% | 2566.67% | 105.27% | 100/158 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | -15.19% | -481.99% | -699.47% | 123/158 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | -1.9% | -172.8% | 42.6% | 100/158 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | -3.31% | -484.88% | -11133.33% | 117/158 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 0.03% | -97.69% | 101.15% | 88/158 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | -2.61% | 73.77% | -200% | 118/158 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 2.61% | -43.75% | 203.49% | 89/158 | 7.48% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 0.86% | -68.5% | -33.85% | 100/158 | 4.96% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.3% | -46.72% | 113.07% | 74/158 | 2.41% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | -9.95% | -224.38% | -314.44% | 126/158 | 6.99% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 4.64% | -48.33% | 69.96% | 71/158 | 7.18% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 2.73% | -43.83% | 11.89% | 73/158 | 4.6% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.44% | -21.04% | -69.5% | 44/158 | 2.54% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 8% | -60.36% | -10.91% | 65/158 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 8.98% | -57.92% | 84.77% | 36/158 | 8.29% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 4.86% | -56.26% | 57.28% | 45/158 | 5.58% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 3.09% | -45.69% | -84.69% | 24/158 | 2.09% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 20.18% | -2.37% | -5.44% | 24/158 | 6.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 21.34% | 35.66% | 92.08% | 5/158 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 11.11% | 7.34% | 95.25% | 10/158 | 3.48% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 5.69% | 5.96% | -72.47% | 9/158 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 20.67% | -10.56% | 31.4% | 21/158 | 11.27% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 15.73% | -23.94% | 51.98% | 9/158 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 10.35% | 26.84% | 92.74% | 11/158 | 4.87% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 5.37% | -41.44% | -76.76% | 10/158 | 2.41% | 华东医药 | 26.63% | 行业排名> |